Samjin Pharmaceutical Co Ltd
KRX:005500
Samjin Pharmaceutical Co Ltd
Revenue
Samjin Pharmaceutical Co Ltd
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
S
|
Samjin Pharmaceutical Co Ltd
KRX:005500
|
Revenue
₩294.7B
|
CAGR 3-Years
8%
|
CAGR 5-Years
3%
|
CAGR 10-Years
4%
|
Yuhan Corp
KRX:000100
|
Revenue
₩1.9T
|
CAGR 3-Years
3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
7%
|
|
SK Biopharmaceuticals Co Ltd
KRX:326030
|
Revenue
₩354.9B
|
CAGR 3-Years
139%
|
CAGR 5-Years
218%
|
CAGR 10-Years
N/A
|
|
Hanmi Pharm Co Ltd
KRX:128940
|
Revenue
₩1.5T
|
CAGR 3-Years
11%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
S
|
Sam Chun Dang Pharm Co Ltd
KOSDAQ:000250
|
Revenue
₩197B
|
CAGR 3-Years
6%
|
CAGR 5-Years
4%
|
CAGR 10-Years
6%
|
C
|
Celltrion Pharm Inc
KOSDAQ:068760
|
Revenue
₩395.8B
|
CAGR 3-Years
13%
|
CAGR 5-Years
20%
|
CAGR 10-Years
23%
|
See Also
What is Samjin Pharmaceutical Co Ltd's Revenue?
Revenue
294.7B
KRW
Based on the financial report for Mar 31, 2024, Samjin Pharmaceutical Co Ltd's Revenue amounts to 294.7B KRW.
What is Samjin Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
4%
Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Samjin Pharmaceutical Co Ltd have been 8% over the past three years , 3% over the past five years , and 4% over the past ten years .